Kazia Therapeutics Limited
KZIA
$3.30
-$0.2395-6.77%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -27.77% | 10.96% | 40.88% | 33.13% | 24.21% |
| Total Depreciation and Amortization | -2.60% | -3.94% | -4.43% | -6.60% | -7.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 674.39% | 468.61% | -2,435.70% | -370.54% | -82.30% |
| Change in Net Operating Assets | 125.73% | 61.28% | -19.96% | 60.99% | 370.18% |
| Cash from Operations | 38.46% | 39.65% | 40.17% | 39.64% | 38.26% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -55.46% | -22.53% | 21.26% | 79.11% | 216.96% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 6.04% | -22.90% | -46.43% | -13.88% | 18.67% |
| Cash from Financing | -55.18% | -23.37% | 20.06% | 77.34% | 225.82% |
| Foreign Exchange rate Adjustments | -80.88% | -100.38% | -102.17% | -97.35% | -94.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -65.82% | 68.02% | 93.16% | 91.48% | 90.36% |